Form 4: Hims & Hers Health Chief Legal Officer Sells Shares Under 10b5-1 Plan
SEC Form 4
Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 2,503 shares of Class A Common Stock at $13.95 per share on April 15, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On April 15, 2024, Soleil Boughton, the Chief Legal Officer of Hims & Hers Health, Inc., sold 2,503 shares of Class A Common Stock.
- The sale was executed at a price of $13.95 per share.
- Following the transaction, Boughton directly owns 164,363 shares of Hims & Hers Health, Inc.
- The sale was conducted under a Rule 10b5-1 trading plan adopted by Boughton on September 8, 2023.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a routine stock sale under a pre-arranged trading plan. There is no indication of positive or negative implications for the company.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. The use of 10b5-1 trading plans is a common practice to avoid accusations of insider trading, allowing insiders to sell shares at predetermined times and prices.
Stakeholder Impact
- The sale of shares by a company officer could be perceived neutrally or slightly negatively by shareholders, depending on their individual investment strategies and interpretations of insider activity.
Key Dates
| Date | Description |
|---|---|
| 2023-09-08 | Date of adoption of Rule 10b5-1 trading plan |
| 2024-04-15 | Date of transaction: Sale of 2,503 shares of Class A Common Stock |
| 2024-04-16 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.